✦ LIBER ✦

Phase I Study of RGB-286638, A Novel, Multitargeted Cyclin-Dependent Kinase Inhibitor in Patients with Solid Tumors

✍ Scribed by van der Biessen, D. A. J.; Burger, H.; de Bruijn, P.; Lamers, C. H. J.; Naus, N.; Loferer, H.; Wiemer, E. A. C.; Mathijssen, R. H. J.; de Jonge, M. J. A.

Book ID: 126491595
Publisher: American Association for Cancer Research
Year: 2014
Tongue: English
Weight: 589 KB
Volume: 20
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.CCR-14-0325

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

403 Phase I study on RGB-286638, a novel

403 Phase I study on RGB-286638, a novel, multi-targeted protein kinase inhibitor, administered as a 1-hour infusion on five consecutive days every 4 weeks in patients (pts) with recurrent or refractory solid tumors

✍ M. de Jonge; R. Mathijssen; W. Loos; H. Loferer; S. Sperka; T. Meyer; E. Wiemer; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Phase I dose escalation study of MK-0457

Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors

✍ Anne M. Traynor; Maureen Hewitt; Glenn Liu; Keith T. Flaherty; Jason Clark; Stev 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 252 KB

Phase I evaluation of seliciclib (R-rosc

Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies

✍ Christophe Le Tourneau; Sandrine Faivre; Valérie Laurence; Catherine Delbaldo; K 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 378 KB

281 POSTER A phase I study of R547, a no

281 POSTER A phase I study of R547, a novel cyclin dependent kinase inhibitor, in patients (pts) with advanced cancer: preliminary results

✍ D.R. Camidge; S.G. Eckhardt; A. Tan; G. Frenette; S. Diab; W. Depinto; J.F. Grip 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Phase I study of AG 331, a novel thymidy

Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumors

✍ Robert T. Koda; Agustin A. Garcia; Dhruba J. Chatterjee; Wen Yen Li; Deepika Par 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 153 KB

A phase I schedule dependency study of t

A phase I schedule dependency study of the aurora kinase inhibitor MSC1992371A in combination with gemcitabine in patients with solid tumors

✍ Raymond, E.; Alexandre, J.; Faivre, S.; Goldwasser, F.; Besse-Hammer, T.; Gianel 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 270 KB